Nephrotic Syndrome Flashcards

1
Q

Investigations of glomerular disease.

A

Urine microscopy - red cells

Urinary proteins

Serum urea

Serum creatinine

Culture - throat, ear, skin swab

CXR

Renal imaging

Renal biopsy

Antistreptolysin-O titre

C3 and C4 levels

ANA, ANCA, Anti-GBM, Cryoglobulins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is nephrotic syndrome characterised by?

A

Oedema

Hypoalbuminaemia

> 3.5g proteinuria in a day

Hyperlipidaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What causes hyperlipidaemia in nephrotic syndrome?

A

Increased synthesis of lipoproteins due to low albumin.

LDL increases partly due to upregulation of PCSK9 causing internalisation of LDL receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pathophysiology of nephrotic syndrome.

A

Podocyte pathology -> proteinuria

Membranous nephropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Management of oedema in nephrotic syndrome.

A
Fluid (1L/day) and salt restriction.
Give furosemide (if gut oedema give IV)
Daily weights for guidance.

Aim for 0.5kg to 1kg weight loss per day.

Thiazide if resistant oedema.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Management of proteinuria in nephrotic syndrome.

A

ACEi or ARBs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Common complications in nephrotic syndrome.

A

Thromboembolism

Infection

Hyperlipidaemia

Progression of CKD

Hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cause of thromboembolism in nephrotic syndrome and treatment.

A

Hypercoagulable due to more clotting factors, less anti-thrombin III, and patelet abnormalities.

This leads to increased of VTE, DVT and PE and renal vein thrombosis.

Treated with LMWH and warfarin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What predisposes nephrotic syndrome patients to infection?

A

Urine losses of immunoglobulins and immune mediators.

This leads to increased risk of urinary, resp and CNS infections.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Primary causes of nephrotic syndrome.

A

Minimal change disease

Focal segmental glomerulosclerosis (FSGS)

Membranous nephropathy

Membranoprolfierative glomerulonephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Secondary causes of nephrotic syndrome.

A

DM

Lupus nephritis of SLE

Myeloma

Amyloid

Pre-eclampsia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Give examples of conditions that may have nephrotic range proteinuria but not necessarily other nephrotic features.

A

Amyloidosis

Diabetes

Myeloma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Epidemiology of MCD.

A

Most common form of GN in children.

Condition accounts for 20-25% of cases of adult nephrotic syndrome.

Oedema usually present predominantly around face as a child.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Causes of MCD.

A

Idiopathic most common

Drugs such as NSAIDs and lithium

Paraneoplastic due to haematological malignancy like Hodgkin’s lymphoma

Does not cause renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Diagnosis of MCD.

A

Light microscopy is normal and is why it is called minimal change.

Electron microscopy shows effacement of podocyte foot processes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment of MCD.

A

Prednisolone 1mg/kg for 4-16 weeks.

75% of adults will respond and > 50% will relapse.

If there are frequent relapses try increased dose of prednisolone or try a DMARD like cychlophosphamide or calcineurin inhibitors.

Rituximab can be tried.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the most common glomerulonephritis seen on renal biopsy?

A

FSGS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Causes of FSGS.

A

Primary (idiopathic)

Secondary such as HIV, Heroin, lithium, lymphoma, other scarring.

19
Q

Complications of FSGS.

A

Risk of progressive CKD and kidney failure.

Increased proteinuria worsens prognosis.

20
Q

Diagnosis of FSGS.

A

Glomeruli have scarring of certain segments. Scerotic glomerular lesions that affects some but not all glomeruli as well as segments of each tuft.

May miss early disease if < 10 glomeruli in biopsy sample.

21
Q

Treatment of FSGS.

A

ACEi/ARBs and BP control in all.

Corticosteroids only in primary disease.

Remission in around 25% and partial remission in up to 50%.

Calcineurin inhibitors can be considered as second line.

Plasma exchange and rituximab in reccurence in transplants.

22
Q

Epidemiology of membranous nephropathy.

A

25% of adult nephrotic syndrome.

23
Q

Causes of membranous nephropathy.

A

Primary (idiopathic)

Secondary:

Lung, breast, GI, prostate haematological malignancy

Infection such as hep B and C, Streptococcus, malaria and schistosomiasis

Immunological disease like SLE, RA, Sarcoidosis and Sjögren’s

Drugs like gold and penicillamine

24
Q

Diagnosis of membranous nephropathy.

A

Anti-phospholipase A2 receptor antibody for idiopathic

Diffusely thicked GBM due to subepithelial depsotis (IgG4 dominant in idiopathic and IgGS in secondary)

Spikes on silver stain

25
Q

Treatment of membranous nephropathy.

A

ACEi/ARBs and BP control in all.

Immunosuppression only in those with high risk of progression ( >4g proteinuria without response to ACEi/ARBs)

Treatment of underlying cause in secondary

26
Q

Epidemiology of membranoproliferative glomerulonephritis.

A

10% of adult nephrotic syndrome.

27
Q

Types of membranoproliferative GN.

A

Immune-complex associated

C3 glomerulopathy

28
Q

Explain immune-complex associated membranoproliferative GN.

A

Driven by increased or abnormal immune complexes which deposit in the kidneys and activate complement.

There is usually an underlying cause such as infection, cryoglobulinaemia, monoclonal gammopathy or autoimmunity.

29
Q

Explain C3 glomerulopathy

A

Genetic or acquired defect in the alternative complement pathway.

30
Q

Diagnosis of membranoproliferative GN.

A

Proliferative glomerulonephritis with electron dense deposits.

Immunoglobulin deposition distinguishes between immuno-complex associated and C3 glomerulopathy.

31
Q

Treatment of membranoproliferative GN.

A

ACEi/ARBs and BP control.

Treat underlying cause.

Trial of immunosupp if no underlying cause is found or if there is progressive decline.

32
Q

What is amyloidosis?

A

A group of disorders characterised by extracellular deposits of a protein in abnormal fibrillar form, resistant to degradation.

The ones discussed in this session are systemic forms, it can however also be seen in Alzheimer’s, T2DM and haemodialysis related amyloidosis.

33
Q

Give examples of types of systemic amyloidosis.

A

AL amyloidosis

AA amyloidosis

Familial amyloidoses

34
Q

What is AL amyloidosis?

A

There is proliferation of plasma cell clones related to multiple myeloma.

This leads to amyloidogenic monoclonal immunoglobulins leading to fibrillar light chain protein deposition.

Depositions lead to organ failure and ultimately death.

35
Q

Associations of AL amyloidosis.

A

Myleoma

Waldenström’s

Lymphoma

36
Q

Organs involved in AL amyloidosis

A

Kidneys - glomerular lesions, proteinuria and nephrotic syndrome

Heart - restrictive cardiomyopathy

Nerves - peripheral and autonomic neuropathy + carpal tunnel

Gut - macroglossia, malabsorption, weight loss, perforation, hepatomegaly

Vascular - purpura (periorbital)

37
Q

Treatment of AL amyloidosis.

A

Optimise nutrition, PO melphalan and prednisolone to extend survival.

Stem cell transplant

38
Q

What is AA amyloidosis?

A

Secondary amyloidosis where the amyloid is derived from serum amyloid A.

It is an acute phase protein associated with chronic inflammation in RA, UC/Crohn’s and untreated familial mediterranean fever.

Also with chronic infections such as TB, bronchiectasis and osteomyelitis.

39
Q

Organ involves in AA amyloidosis.

A

Kidneys - proteinuria and nephrotic syndrome may be present

Liver - hepatomegaly

Spleen - splenomegaly

No macroglossia

Cardiac is rare

40
Q

Treatment of AL amyloidosis.

A

Manage underlying condition

41
Q

What is familial amyloidosis?

A

Autosomal dominant from mutation in transthyretin. This is a transport protein produced in the liver.

Usually causes senosry or autonomic neuropathy.

Renal involvment

Cardiac involvment

No macroglossia

42
Q

Treatment of familial amyloidosis.

A

Liver transplant can cure it.

43
Q

Diagnosis of amyloidosis.

A

Biopsy of affected tissue.

Positive congo red staining with apple-green birefringence under polarised light microscopy.

Rectum or subcut fat is +ve in 80% of cases.

44
Q

Prognosis of amyloidosis.

A

Median survival is 1-2 years.

Patients with myeloma and amyloidosis have a shorter survival than those with myeloma alone.